share_log

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144：拟议出售证券
SEC announcement ·  04/02 15:26
Moomoo AI 已提取核心信息
Teladoc Health, Inc. officer Nanis Nikolaos P. is set to sell 461 shares of common stock on 04/02/2024, as announced in a recent filing. The shares to be sold were acquired on 04/01/2024 through restricted stock vesting, as part of compensation from the issuer. This transaction follows a history of sales over the past three months, where a total of 3,386 shares were sold by the officer for gross proceeds of $52,708.34.
Teladoc Health, Inc. officer Nanis Nikolaos P. is set to sell 461 shares of common stock on 04/02/2024, as announced in a recent filing. The shares to be sold were acquired on 04/01/2024 through restricted stock vesting, as part of compensation from the issuer. This transaction follows a history of sales over the past three months, where a total of 3,386 shares were sold by the officer for gross proceeds of $52,708.34.
正如在最近的一份文件中宣布的那样，Teladoc Health, Inc.高管纳尼斯·尼古拉奥斯·P. 定于2024年2月4日出售461股普通股。作为发行人补偿的一部分，拟出售的股票于2024年1月4日通过限制性股票归属收购。该交易遵循了过去三个月的销售历史，该高管共出售了3,386股股票，总收益为52,708.34美元。
正如在最近的一份文件中宣布的那样，Teladoc Health, Inc.高管纳尼斯·尼古拉奥斯·P. 定于2024年2月4日出售461股普通股。作为发行人补偿的一部分，拟出售的股票于2024年1月4日通过限制性股票归属收购。该交易遵循了过去三个月的销售历史，该高管共出售了3,386股股票，总收益为52,708.34美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息